Litcius/Paper detail

Cytokine signature and COVID-19 prediction models in the two waves of pandemics

Serena Cabaro, Vittoria D’Esposito, Tiziana Di Matola, Silvia Sale, Michele Cennamo, Daniela Terracciano, Valentina Parisi, Francesco Oriente, Giuseppe Portella, Francesco Bèguinot, Luigi Atripaldi, Mario Sansone, Pietro Formisano

2021Scientific Reports74 citationsDOIOpen Access PDF

Abstract

In Europe, multiple waves of infections with SARS-CoV-2 (COVID-19) have been observed. Here, we have investigated whether common patterns of cytokines could be detected in individuals with mild and severe forms of COVID-19 in two pandemic waves, and whether machine learning approach could be useful to identify the best predictors. An increasing trend of multiple cytokines was observed in patients with mild or severe/critical symptoms of COVID-19, compared with healthy volunteers. Linear Discriminant Analysis (LDA) clearly recognized the three groups based on cytokine patterns. Classification and Regression Tree (CART) further indicated that IL-6 discriminated controls and COVID-19 patients, whilst IL-8 defined disease severity. During the second wave of pandemics, a less intense cytokine storm was observed, as compared with the first. IL-6 was the most robust predictor of infection and discriminated moderate COVID-19 patients from healthy controls, regardless of epidemic peak curve. Thus, serum cytokine patterns provide biomarkers useful for COVID-19 diagnosis and prognosis. Further definition of individual cytokines may allow to envision novel therapeutic options and pave the way to set up innovative diagnostic tools.

Topics & Concepts

Cytokine stormPandemicCoronavirus disease 2019 (COVID-19)CytokineLinear discriminant analysisImmunologyMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Severity of illnessRegression2019-20 coronavirus outbreakDiseaseInternal medicineVirologyOutbreakComputer scienceArtificial intelligenceStatisticsInfectious disease (medical specialty)MathematicsCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19